Document:

Exhibit 10.78

 EXHIBIT 10.78 
  
 $40,000,000 AGGREGATE PRINCIPAL AMOUNT 
  
 BEARINGPOINT, INC. 
  
 0.50% CONVERTIBLE SENIOR SUBORDINATED DEBENTURES 
 DUE JULY 2010 
  
 AND 
  
 COMMON STOCK PURCHASE WARRANTS 
  
 Registration Rights Agreement 
  
 dated July 15, 2005 

 REGISTRATION RIGHTS AGREEMENT, dated as of July 15, 2005, between BearingPoint, Inc., a Delaware
corporation (together with any successor entity, herein referred to as the “Company”), and each of the other entities whose names are set forth on the signature page hereto (the “Investors”).

  
 Pursuant to the Securities Purchase Agreement, dated as of
July 15, 2005 (the “Purchase Agreement”), by and between the Company and the Investors, the Company has agreed to issue and sell to the Investors $40,000,000 aggregate principal amount of its 0.50% Convertible Senior
Subordinated Debentures due July 2010 (the “Debentures”) and Warrants to Purchase Common Stock (the “Warrants”, and, together with the Debentures, the “Securities”). The
Securities are convertible or exercisable, as the case may be, into fully paid, nonassessable shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”). 
  
 To induce the Investors to enter into the Purchase Agreement, the Company has
agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement. 
  
 The Company agrees with the Investors for the benefit of the Investors and the other beneficial owners (if any) from time to
time of the Securities and the beneficial owners from time to time of the underlying Common Stock issued upon conversion or exercise of the Securities (each of the foregoing, including the Investors, a “Holder” and together the
“Holders”), as follows: 
  
 The parties
hereby agree as follows: 
  
 1. Definitions. Capitalized
terms used in this Agreement without definition shall have their respective meanings set forth in the Purchase Agreement. As used in this Agreement, the following capitalized terms shall have the following meanings: 
  
 “Affiliate” of any specified Person means any other Person
which, directly or indirectly, is in control of, is controlled by, or is under common control with, such specified Person. For purposes of this definition, control of a Person means the power, direct or indirect, to direct or cause the direction of
the management and policies of such Person whether by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 
  
 “Agreement” means this Registration Rights Agreement.

  
 “Amendment Effectiveness Deadline Date” has
the meaning set forth in Section 2(e) hereof 
  
 “Amendment Filing Target Date” has the meaning set forth in Section 2(e) hereof.  
  
 “Asserting Person” has the meaning set forth in Section 6(a) hereof. 
  
 “Business Day” means a day, other than a Saturday or Sunday, that in The City of New York, is not a day on
which banking institutions are authorized or required by law, regulation or executive order to close. 
  

 - 1 - 

 “Commission” means the Securities and Exchange Commission.  
  
 “Common Stock” has the meaning set forth in the preamble
hereto.  
  
 “Company” has the meaning set
forth in the preamble hereto.  
  
 “Effectiveness
Period” has the meaning set forth in Section 2(a)(iii) hereof.  
  
 “Effectiveness Target Date” has the meaning set forth in Section 2(a)(ii) hereof.  
  
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
  
 “Holder” means a Person who owns, beneficially or otherwise,
Transfer Restricted Securities. 
  
 “Indemnified
Holder” has the meaning set forth in Section 6(a) hereof. 
  
 “Majority of Holders” means, at any time of determination, Holders holding more than 50% of the Transfer Restricted Securities outstanding. 
  
 “NASD” means the National Association of Securities Dealers, Inc. 
  
 “Notice and Questionnaire” means a written notice executed
by the respective Holder and delivered to the Company containing substantially the information called for by the Selling Securityholder Notice and Questionnaire attached hereto as Annex A. 
  
 “Notice Holder” means on any date, any Holder that has
delivered a Notice and Questionnaire to the Company on or prior to such date. 
  
 “Person” means an individual, partnership, corporation, company, unincorporated organization, trust, joint venture or a government or agency or political subdivision thereof. 
  
 “Purchase Agreement” has the meaning set forth in the
preamble hereto. 
  
 “Prospectus” means the
prospectus included in a Shelf Registration Statement, as amended or supplemented by any prospectus supplement and by all other amendments thereto, including post-effective amendments, and all material incorporated by reference into such prospectus.

  
 “Registration Default” has the meaning set
forth in Section 3(a) hereof.  
  
 “Securities” has the meaning set forth in the preamble hereto.  
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  
 “Selling Holder” means a Holder that is named as a selling holder in the Shelf Registration Statement.

  
 “Shelf Filing Deadline” has the meaning set
forth in Section 2(a)(i) hereof. 
  

 - 2 - 

 “Shelf Registration Statement” has the meaning set forth in Section 2(a)(i) hereof.

  
 “Subsequent Shelf Registration Statement” has
the meaning set forth in Section 2(c) hereof. 
  
 “Suspension Notice” has the meaning set forth in Section 4(c) hereof.  
  
 “Suspension Period” has the meaning set forth in Section 4(b)(i) hereof. 
  
 “Transfer Restricted Securities” means each share of Common
Stock issued upon conversion or exercise, as the case may be, of a Security until the earliest of: 
  
 (i) the date on which such share of Common Stock has been effectively registered under the Securities Act and disposed of in accordance
with the Shelf Registration Statement; 
  
 (ii)
the date on which such share of Common Stock is transferred in compliance with Rule 144 under the Securities Act; or 
  
 (iii) the date on which such share of Common Stock ceases to be outstanding (whether as a result of redemption, repurchase and
cancellation, conversion or otherwise). 
  
 “Underwritten
Registration” means a registration in which Securities are sold to an underwriter for reoffering to the public. 
  
 Unless the context otherwise requires, the singular includes the plural, and words in the plural include the singular. 
  
 2. Shelf Registration. 
  
 (a) The Company shall: 
  
 (i) not later than December 31, 2005 (the
“Shelf Filing Deadline”), cause to be filed a registration statement pursuant the Securities Act (the “Shelf Registration Statement”), which Shelf Registration Statement shall provide for resales of
all Transfer Restricted Securities held by Holders that become entitled to be named as a selling securityholder in such Shelf Registration Statement and the related Prospectus pursuant to the terms of Section 2(b) hereof; 
  
 (ii) use its reasonable best efforts to cause the Shelf
Registration Statement to be declared effective by the Commission not later than March 31, 2006 (the “Effectiveness Target Date”); and 
  
 (iii) use its reasonable best efforts to keep the Shelf Registration Statement continuously effective,
supplemented and amended as required by the provisions of Section 4(b) hereof to the extent necessary to ensure that (A) it is available for resales by the Holders and (B) it conforms with the requirements of 

  

 - 3 - 

 
this Agreement and the Securities Act and the rules and regulations of the Commission promulgated thereunder as announced from time to time, for a period
(the “Effectiveness Period”) until the earlier of: 
  
 (1) the date when the Holders are able to sell all Transfer Restricted Securities immediately without restriction during any three (3) month period pursuant to the provisions of Rule 144 under the Securities Act
or any similar provision then in effect, or 
  
 (2) the date when all of the Transfer Restricted Securities are sold pursuant to the Shelf Registration Statement or pursuant to Rule 144 under the Securities Act or any similar provision then in effect. 
  
 (b) At the time the Shelf Registration Statement is declared
effective, each Holder that became a Notice Holder on or prior to the date eight (8) Business Days prior to such time of effectiveness shall be named as a selling securityholder in the Shelf Registration Statement and the related Prospectus in
such a manner as to permit such Holder to deliver such Prospectus to purchasers of Transfer Restricted Securities in accordance with applicable law. None of the Company’s securityholders (other than Holders) shall have the right to include any
of the Company’s securities in the Shelf Registration Statement. 
  
 (c) If the Shelf Registration Statement or any Subsequent Shelf Registration Statement ceases to be effective for any reason at any time during the Effectiveness Period (other than because all Transfer Restricted
Securities registered thereunder shall have been resold pursuant thereto or shall have otherwise ceased to be Transfer Restricted Securities), the Company shall use its reasonable best efforts to, as promptly as is practicable, obtain the withdrawal
of any order suspending the effectiveness thereof, and in any event shall, to the extent necessary, within thirty (30) days of such cessation of effectiveness amend the Shelf Registration Statement in a manner reasonably expected to obtain the
withdrawal of the order suspending the effectiveness thereof, or file an additional Shelf Registration Statement covering all of the securities that as of the date of such filing are Transfer Restricted Securities (a “Subsequent Shelf
Registration Statement”). If a Subsequent Shelf Registration Statement is filed, the Company shall use its reasonable best efforts to cause the Subsequent Shelf Registration Statement to become effective as promptly as is practicable
after such filing and to keep such Subsequent Registration Statement continuously effective until the end of the Effectiveness Period. 
  
 (d) The Company shall supplement and amend the Shelf Registration Statement if required by the rules, regulations or instructions
applicable to the registration form used by the Company for such Shelf Registration Statement, if required by the Securities Act or as reasonably requested by the Holders covered by such Shelf Registration Statement. 
  
 (e) Each Holder agrees that if such Holder wishes to sell
Transfer Restricted Securities pursuant to a Shelf Registration Statement and related Prospectus, it shall do so 

  

 - 4 - 

 
only in accordance with this Section 2(e) and Section 4. From and after the date the Shelf Registration Statement is declared effective the Company
shall, as promptly as practicable after the date a Notice and Questionnaire is delivered, and in any event upon the later of (x) fifteen (15) Business Days after such date or (y) fifteen (15) Business Days after the expiration of
any Suspension Period in effect when the Notice and Questionnaire is delivered or put into effect within fifteen (15) Business Days of such delivery date (each such date described in (x) and (y) above, the “Amendment Filing
Target Date”): 
  
 (i) if
required by applicable law, file with the Commission a posteffective amendment to the Shelf Registration Statement or prepare and, if required by applicable law, file a supplement to the related Prospectus or a supplement or amendment to any
document incorporated therein by reference or file any other required document so that the Holder delivering such Notice and Questionnaire is named as a selling securityholder in the Shelf Registration Statement and the related Prospectus in such a
manner as to permit such Holder to deliver such Prospectus to purchasers of the Transfer Restricted Securities in accordance with applicable law and, if the Company shall file a post-effective amendment to the Shelf Registration Statement, use its
reasonable best efforts to cause such post-effective amendment to be declared effective under the Securities Act as promptly as is practicable, but in any event by the date (the “Amendment Effectiveness Deadline Date”) that
is forty-five (45) days after the date such post effective amendment is required by this clause to be filed; 
  
 (ii) provide such Holder copies of any documents filed pursuant to Section 2(e)(i); and 
  
 (iii) notify such Holder as promptly as practicable after
the effectiveness under the Securities Act of any post-effective amendment filed pursuant to Section 2(e)(i); 
  
 provided that if such Notice and Questionnaire is delivered during a Suspension Period, the Company shall so inform the Holder delivering such Notice and
Questionnaire and shall take the actions set forth in clauses (i), (ii) and (iii) above upon expiration of the Suspension Period in accordance with Section 4(b). Notwithstanding anything contained herein to the contrary, (i) the
Company shall be under no obligation to name any Holder that is not a Notice Holder as a selling securityholder in any Registration Statement or related Prospectus and (ii) the Amendment Effectiveness Deadline Date shall be extended by up to
ten (10) Business Days from the expiration of a Suspension Period (and the Company shall incur no increase in the interest rate applicable to the Debentures under Section 2.1 (iii) of the Debentures during such extension) if such
Suspension Period shall be in effect on the Amendment Effectiveness Deadline Date. 
  

 - 5 - 

 3. Registration Default. 
  
 (a) Each event referred to in the following clauses (i) through (v) is a “Registration
Default”: 
  
 (i) the Shelf Registration
Statement is not filed with the Commission prior to or on the Shelf Filing Deadline; 
  
 (ii) the Shelf Registration Statement has not been declared effective by the Commission prior to or on the Effectiveness Target Date;

  
 (iii) except as provided in
Section 4(b)(i) hereof, the Shelf Registration Statement is filed and declared effective but, during the Effectiveness Period, shall thereafter cease to be effective or fail to be usable for its intended purpose without being succeeded within
five (5) Business Days by a post-effective amendment to the Shelf Registration Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures
such failure and, in the case of a post-effective amendment, is itself immediately declared effective; 
  
 (iv) a post-effective amendment or a supplement to a related Prospectus required pursuant to Section 2(e) is not filed by the
Amendment Filing Target Date or declared effective on or prior to the Amendment Effectiveness Deadline Date; or 
  
 (v) (A) prior to or on the 45th or 60th day, as the case may be, of any Suspension Period, such suspension has not been terminated or
(B) Suspension Periods exceed an aggregate of 90 days in any 360-day period. 
  

 - 6 - 

 For purposes of this Agreement, each Registration Default set forth above shall begin and be cured on the
dates set forth in the table below: 
  

					
	 Type of
Registration
Default by Clause

	  	 Beginning Date  

	  	 Cure Date  

	(i)	  	Shelf Filing Deadline	  	the date the Shelf Registration Statement is filed
			
	(ii)	  	Effectiveness Target Date	  	the date the Shelf Registration Statement is declared effective by the Commission
			
	(iii)	  	the date five (5) Business Days following the date that the Shelf Registration Statement ceases to be effective or fails to be usable	  	the date any post-effective amendment is declared effective by the Commission or any supplement to the Prospectus or report is filed that makes the Shelf Registration Statement
usable
			
	(iv)	  	Amendment Filing Target Date	  	the date the prospectus supplement or post-effective amendment is filed
			
	 	  	Amendment Effectiveness Deadline Date	  	the date any required post-effective amendment is declared effective by the Commission
			
	(v)	  	the date on which a Suspension Period, or the aggregate duration of Suspension Periods in any period, exceeds the permitted number of days	  	termination of the applicable Suspension Period

  
 In the absence of any
intentional misconduct by the Company, the increased interest rate set forth in Section 2.1 (iii) of the Debentures shall be the exclusive monetary remedies available to the Holders for each Registration Default. 
  
 4. Registration Procedures. 
  
 (a) In connection with the Shelf Registration Statement, the
Company shall comply with all the provisions of Section 4(b) hereof and shall use its reasonable best efforts to effect such registration to permit the sale of the Transfer Restricted Securities, and pursuant thereto, shall prepare and file
with the Commission a Shelf Registration Statement relating to the registration on any appropriate form under the Securities Act. 
  
 (b) In connection with the Shelf Registration Statement and any Prospectus required by this Agreement to permit the sale or resale of
Transfer Restricted Securities, the Company shall: 
  
 (i) Subject to any notice by the Company in accordance with this Section 4(b) of the existence of any fact or event of the kind described in Section 4(b)(iii)(D), use its reasonable best efforts to keep the Shelf Registration

  

 - 7 - 

 
Statement continuously effective during the Effectiveness Period; upon the occurrence of any event that would cause the Shelf Registration Statement or the
Prospectus contained therein (A) to contain a material misstatement or omission or (B) not to be effective and usable for resale of Transfer Restricted Securities during the Effectiveness Period, the Company shall file as promptly as is
practicable an appropriate amendment to the Shelf Registration Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, in the case of clause (A),
correcting any such misstatement or omission, and, in the case of either clause (A) or (B), use its reasonable best efforts to cause such amendment to be declared effective and the Shelf Registration Statement and the related Prospectus to
become usable for their intended purposes as soon as practicable thereafter. Notwithstanding the foregoing, the Company may suspend the effectiveness of the Shelf Registration Statement by written notice to the Holders for a period not to exceed an
aggregate of 45 days in any 90-day period (each such period, a “Suspension Period”) if: 
  
 (x) there are certain circumstances relating to pending corporate developments, public filings with the Commission or similar events;

  
 (y) an event occurs and is continuing as a
result of which the Shelf Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein would, in the Company’s judgment, contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading; and 
  
 (z) the Company determines reasonably and in good faith that the disclosure of such event at such time would be seriously detrimental to
the Company and its subsidiaries; 
  
 provided that, in the event the
disclosure relates to a previously undisclosed proposed or pending material business transaction, the disclosure of which the Company determines in good faith would be reasonably likely to impede the Company’s ability to consummate such
transaction, the Company may extend a Suspension Period from 45 days to 60 days; provided, however, that Suspension Periods shall not exceed an aggregate of 90 days in any 360-day period. The Company shall not specify in the written
notice to the Holders the nature of the event giving rise to the Suspension Period. 
  
 (ii) Prepare and file with the Commission such amendments and post-effective amendments to the Shelf Registration Statement as may be
necessary to keep the Shelf Registration Statement effective during the Effectiveness Period; cause the Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities
Act, and to comply fully with the applicable provisions of Rules 424 and 430A under the Securities Act in a timely manner; and comply with the provisions of the Securities Act with respect to the disposition of all Securities covered by the Shelf

  

 - 8 - 

 
Registration Statement during the applicable period in accordance with the intended method or methods of distribution by the sellers thereof set forth in the
Shelf Registration Statement or supplement to the Prospectus. 
  
 (iii) Advise each Selling Holder as promptly as is practicable and, if requested by such Selling Holder, to confirm such advice in writing, except as provided in clause (D) below: 
  
 (A) when the Prospectus or any supplement to the Prospectus
or post-effective amendment has been filed, and, with respect to the Shelf Registration Statement or any post-effective amendment thereto, when the same has become effective; 
  
 (B) of any request by the Commission for amendments to the Shelf Registration Statement or amendments or
supplements to the Prospectus or for additional information relating thereto; 
  
 (C) of the issuance by the Commission of any stop order suspending the effectiveness of the Shelf Registration Statement under the
Securities Act or of the suspension by any state securities commission of the qualification of the Transfer Restricted Securities for offering or sale in any jurisdiction, or the initiation of any proceeding for any of the preceding purposes; or

  
 (D) of the existence of any fact or the
happening of any event, during the Effectiveness Period, that makes any statement of a material fact made in the Shelf Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein
untrue, or that requires the making of any additions to or changes in the Shelf Registration Statement or the Prospectus in order to make the statements therein not misleading. 
  
 If at any time the Commission shall issue any stop order suspending the effectiveness of the Shelf Registration Statement, or any state
securities commission or other regulatory authority shall issue an order suspending the qualification or exemption from qualification of the Transfer Restricted Securities under state securities or Blue Sky laws, the Company shall use its reasonable
best efforts to obtain the withdrawal or lifting of such order at the earliest possible time and shall provide to each Holder who is named in the Shelf Registration Statement notice of the withdrawal of any such order as promptly as is practicable.

  
 (iv) Make available at reasonable times for
inspection by one or more representatives of the Selling Holders, designated in writing by a Majority of Holders whose Transfer Restricted Securities are included in the Shelf Registration Statement, and any attorney or accountant retained by such
Selling Holders, all financial and other records, pertinent corporate documents and properties of the Company as shall be reasonably necessary to enable them to conduct a reasonable investigation within the meaning of Section 11 of the 

  

 - 9 - 

 
Securities Act, and cause the Company’s officers, directors, managers and employees to supply all information reasonably requested by any such
representative or representatives of the Selling Holders, attorney or accountant in connection therewith; provided, however, that the Company shall have no obligation to deliver information to any Selling Holder or representative
pursuant to this Section 4(b)(iv) unless such Selling Holder or representative shall have executed and delivered a confidentiality agreement in a form acceptable to the Company relating to such information. 
  
 (v) If requested by any Selling Holder, incorporate as
promptly as is practicable in the Shelf Registration Statement or Prospectus, pursuant to a supplement or post-effective amendment if necessary, such information as such Selling Holder may reasonably request relating to such Selling Holder or the
plan of distribution of the Transfer Restricted Securities. 
  
 (vi) Furnish to each Selling Holder upon its request, without charge, at least one copy of the Shelf Registration Statement, as first filed with the Commission, and of each amendment thereto (and any exhibits thereto
as such Person may request). 
  
 (vii) Deliver to
each Selling Holder, without charge, as many copies of the Prospectus (including each preliminary Prospectus) and any amendment or supplement thereto as such Persons reasonably may request; subject to any notice by the Company in accordance with
this Section 4(b) of the existence of any fact or event of the kind described in Section 4(b)(iii)(D), the Company hereby consents to the use of the Prospectus and any amendment or supplement thereto by each of the Selling Holders in
connection with the offering and the sale of the Transfer Restricted Securities covered by the Prospectus or any amendment or supplement thereto. 
  
 (viii) Before any public offering of Transfer Restricted Securities, cooperate with the Selling Holders and their counsel in connection
with the registration and qualification of the Transfer Restricted Securities under the securities or Blue Sky laws of such jurisdictions in the United States as the Selling Holders may reasonably request and do any and all other acts or things
necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the Shelf Registration Statement; provided, however, that the Company shall not be required (A) to register or
qualify as a foreign corporation or a dealer of securities where it is not now so qualified or to take any action that would subject it to the service of process in any jurisdiction where it is not now so subject or (B) to subject itself to
general or unlimited service of process or to taxation in any such jurisdiction if they are not now so subject. 
  
 (ix) Cooperate with the Selling Holders to facilitate the timely preparation and delivery of certificates representing Transfer Restricted
Securities to be sold and not bearing any restrictive legends (unless required by applicable 

  

 - 10 - 

 
securities laws); and enable such Transfer Restricted Securities to be in such denominations and registered in such names as the Holders may request at least
two Business Days before any sale of Transfer Restricted Securities. 
  
 (x) Use its reasonable best efforts to cause the Transfer Restricted Securities covered by the Shelf Registration Statement to be registered with or approved by such other U.S. governmental agencies or authorities as
may be necessary to enable the seller or sellers thereof to consummate the disposition of such Transfer Restricted Securities. 
  
 (xi) Subject to Section 4(b)(i) hereof, if any fact or event contemplated by Section 4(b)(iii)(D) hereof shall exist or have
occurred, use its reasonable best efforts to prepare a supplement or post-effective amendment to the Shelf Registration Statement or related Prospectus or any document incorporated therein by reference or file any other required document so that, as
thereafter delivered to the purchasers of Transfer Restricted Securities, the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they are made, not misleading. 
  
 (xii) Provide CUSIP numbers for all Transfer Restricted Securities sold pursuant to the Shelf Registration Statement not later than the
effective date of the Shelf Registration Statement and provide each Selling Holder, in exchange for such Selling Holder’s certificate for its Transfer Restricted Securities, an interest in a global certificate on deposit with The Depository
Trust Company or any successor thereto. 
  
 (xiii) Cooperate and assist in any filings required to be made with the NASD and in the performance of any due diligence investigation by any underwriter that is required to be performed in accordance with the rules and regulations of the
NASD. 
  
 (xiv) Use its reasonable best efforts
to comply with all applicable rules and regulations of the Commission and all reporting requirements under the rules and regulations of the Exchange Act. 
  
 (xv) Cause all Common Stock covered by the Shelf Registration Statement to be listed or quoted, as the case may be, on each securities
exchange or automated quotation system on which Common Stock is then listed or quoted. For the avoidance of doubt, the Shelf Registration Statement shall cover a number of shares of Common Stock equal to the full number of shares of Common Stock
into which the Securities would be convertible assuming the Company does not elect to deliver cash in lieu of shares of Common Stock upon conversion of the Securities. 
  
 (xvi) Provide to each Holder upon written request each document filed with the Commission pursuant to the
requirements of Section 13 and Section 15of the Exchange Act after the effective date of the Shelf Registration Statement, unless such document is available through the Commission’s EDGAR system. 
  

 - 11 - 

 (xvii) Subject to Section 4(b)(i) hereof, take all other actions reasonably
necessary in order to expedite or facilitate the disposition of Transfer Restricted Securities. 
  
 (c) Each Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of any notice (a “Suspension
Notice”) from the Company of the existence of any fact of the kind described in Section 4(b)(iii)(D) hereof, such Holder shall forthwith discontinue disposition of Transfer Restricted Securities pursuant to the Shelf Registration
Statement until: 
  
 (i) such Holder has received
copies of the supplemented or amended Prospectus contemplated by Section 4(b)(xi) hereof; or 
  
 (ii) such Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and has received copies of any
additional or supplemental filings that are incorporated by reference in the Prospectus. 
  
 If so directed by the Company, each Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering
such Transfer Restricted Securities that was current at the time of receipt of such Suspension Notice. 
  
 (d) Each Holder agrees by acquisition of a Security and a Transfer Restricted Security, that no Holder shall be entitled to sell any
Transfer Restricted Securities pursuant to a Shelf Registration Statement, or to receive a Prospectus relating thereto, unless such Holder has furnished the Company with a Notice and Questionnaire as required pursuant to Section 2(b) or 2(e),
as the case may be, hereof (including the information required to be included in such Notice and Questionnaire) and the information set forth in the next sentence. Each Notice Holder agrees promptly to furnish to the Company all information required
to be disclosed in order to make the information previously furnished to the Company by such Notice Holder not misleading and any other information regarding such Notice Holder and the distribution of such Transfer Restricted Securities as the
Company may from time to time reasonably request in writing. Any sale of any Transfer Restricted Securities by any Holder shall constitute a representation and warranty by such Holder that the information relating to such Holder and its plan of
distribution is as set forth in the Prospectus delivered by such Holder in connection with such disposition, that such Prospectus does not as of the time of such sale contain any untrue statement of a material fact relating to or provided by such
Holder to its plan of distribution and that such Prospectus does not as of the time of such sale omit to state any material fact relating to or provided by such Holder or its plan of distribution necessary to make the statements in such Prospectus,
in the light of the circumstances under which they were made, not misleading. 
  

 - 12 - 

 (e) Each Holder agrees by acquisition of a Security and a Transfer Restricted Security
that, upon receipt of any Suspension Notice, such Holder shall keep the existence of a Suspension Period in confidence. 
  
 5. Registration Expenses. 
  
 All expenses incident to the Company’s performance of or compliance with this Agreement shall be borne by the Company regardless of whether a Shelf
Registration Statement becomes effective, including, without limitation: 
  
 (i) all registration and filing fees and expenses (including filings made with the NASD); 
  
 (ii) all fees and expenses of compliance with federal securities and state Blue Sky or securities laws; 
  
 (iii) all expenses of printing (including printing of
Prospectuses and certificates for the Common Stock to be issued upon conversion of the Securities) and the Company’s expenses for messenger and delivery services and telephone; 
  
 (iv) all fees and disbursements of counsel to the Company; 
  
 (v) all application and filing fees in connection with
listing (or authorizing for quotation) of the Common Stock on a national securities exchange or automated quotation system pursuant to the requirements hereof; and 
  
 (vi) all fees and disbursements of independent certified public accountants of the Company. 
  
 The Company shall bear its internal expenses (including, without limitation,
all salaries and expenses of their officers and employees performing legal, accounting or other duties), the expenses of any annual audit and the fees and expenses of any Person, including special experts, retained by the Company. 
  
 All fees and expenses of the Notice Holders, including fees and expenses of
counsel, shall be borne by the Notice Holders; provided that the Company shall pay the reasonable fees and expenses of one law firm selected by the Majority of Holders to represent all Notice Holders. 
  
 6. Indemnification and Contribution. 
  
 (a) The Company agrees to indemnify and hold harmless each
Holder, its directors, officers, and employees and each Person, if any, who controls any such Holder within the meaning of the Securities Act or the Exchange Act (each, an “Indemnified Holder”), against any loss, claim, damage,
liability or expense, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to resales of the Transfer Restricted Securities), to which such Indemnified Holder may
become subject, insofar as any such loss, claim, damage, liability or action arises out of, or is based upon: 
  

 - 13 - 

 (i) any untrue statement or alleged untrue statement of a material fact contained in
(A) the Shelf Registration Statement as originally filed or in any amendment thereof, in any Prospectus or in any amendment or supplement thereto or (B) any blue sky application or other document or any amendment or supplement thereto
prepared or executed by the Company (or based upon written information furnished by or on behalf of the Company expressly for use in such blue sky application or other document or amendment or supplement) filed in any jurisdiction specifically for
the purpose of qualifying any or all of the Transfer Restricted Securities under the securities law of any state or other jurisdiction; or 
  
 (ii) the omission or alleged omission to state therein any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, 
  
 and agrees to reimburse each Indemnified Holder promptly upon demand for any legal or other expenses reasonably incurred by such Indemnified Holder in connection with investigating, defending, settling, compromising or paying any such loss,
claim, damage, liability, expense or action; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or expense arises out of, or is based upon, any untrue
statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Holder (or its related Indemnified Holder) specifically for use
therein; provided, further, that the foregoing indemnity agreement with respect to any Prospectus shall not inure to the benefit of a Holder, or any person controlling such Holder, who failed to deliver a Prospectus, as then amended or
supplemented (so long as the prospectus and any amendment or supplement thereto was provided by the Company to the Holder on a timely basis prior to the sale of Transfer Restricted Securities by such Holder pursuant to a Shelf Registration Statement
to the Asserting Person, in order to permit proper delivery upon confirmation of such sale), to the Person (the “Asserting Person”) asserting any losses, claims, damages, liabilities, expenses or judgments caused by any untrue
statement or alleged untrue statement of a material fact contained in any Prospectus, or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading, if such material misstatement or omission or alleged material misstatement or omission was cured in the Prospectus, as so amended or supplemented. The foregoing indemnity agreement is in addition to any liability which the Company may
otherwise have. 
  
 (b) Each Holder, severally
and not jointly, agrees to indemnify and hold harmless the Company, its directors, officers and employees and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act to the same extent as the
foregoing indemnity from the Company to each such Holder, but only with reference to written information relating to such Holder furnished to the Company by or on behalf of such Holder specifically for inclusion in the documents referred to in the
foregoing indemnity. The indemnity agreement set forth in this Section shall be in addition to any liabilities which any such Holder may otherwise have. In no event shall any Holder, its directors, officers, employees or any Person who controls such
Holder be liable or responsible for any amount in excess of the amount by which the total amount received by such Holder with respect to its sale of Transfer Restricted Securities 

  

 - 14 - 

 
pursuant to a Shelf Registration Statement exceeds the sum of (i) the amount paid by such Holder for such Transfer Restricted Securities plus
(ii) the amount of any damages that such Holder, its directors, officers, employees or any Person who controls such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

  
 (c) Promptly after receipt by an indemnified
party under this Section 6 of notice of any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 6, notify the indemnifying
party in writing of the claim or the commencement of that action; provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section 6 except to the
extent it has been materially prejudiced by such failure and, provided, further, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under
this Section 6. If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes,
jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel satisfactory to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense
of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 6 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than
reasonable costs of investigation; provided, however, that the Holders shall have the right to employ a single counsel to represent jointly the Holders and their directors, officers, employees and controlling persons who may be subject
to liability arising out of any claim in respect of which indemnity may be sought by the Holders against the Company under this Section 6 if the Holders seeking indemnification shall have been advised by legal counsel that there may be one or
more legal defenses available to such Holders and their respective directors, officers, employees and controlling persons that are different from or additional to those available to the Company, and in that event, the fees and expenses of such
separate counsel shall be paid by the Company. 
  
 (d) The indemnifying party under this Section 6 shall not be liable for any settlement of any proceeding effected without its written consent, which shall not be withheld unreasonably, but if settled with such consent or if there is a
final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time
an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by this Section 6(d) hereof, the indemnifying party agrees that it shall be liable for any
settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have
reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry
of judgment 

  

 - 15 - 

 
in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party and indemnity was or could have been sought
hereunder by such indemnified party, unless such settlement, compromise or consent (x) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding and
(y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 
  
 (e) If the indemnification provided for in this Section 6 shall for any reason be unavailable or insufficient to hold harmless an
indemnified party under Section 6(a) or 6(b) in respect of any loss, claim, damage or liability (or action in respect thereof) referred to therein, each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the
amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability (or action in respect thereof): 
  
 (i) in such proportion as is appropriate to reflect the relative benefits received by the Company from the offering and sale of the
Transfer Restricted Securities on the one hand and a Holder with respect to the sale by such Holder on the other hand; or 
  
 (ii) if the allocation provided by Section (6)(e)(i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in Section 6(e)(i) but also the relative fault of the Company on the one hand and the Holders on the other hand in connection with the statements or omissions or alleged statements or alleged
omissions that resulted in such loss, claim, damage or liability (or action in respect thereof), as well as any other relevant equitable considerations. 
  
 The relative benefits received by the Company on the one hand and a Holder on the other hand with respect to such offering and such sale shall be deemed to be in the same
proportion as the total net proceeds from the offering of the Securities purchased under the Purchase Agreement (before deducting expenses) received by the Company, on the one hand, bear to the total proceeds received by such Holder with respect to
its sale of Transfer Restricted Securities on the other hand. The relative fault of the parties shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or the Holders on the other hand, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or
omission. The Company and each Holder agree that it would not be just and equitable if the amount of contribution pursuant to this Section 6(e) were determined by pro rata allocation or by any other method of allocation that does not take into
account the equitable considerations referred to in the first sentence of this Section 6(e). 
  
 The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in
this Section 6 shall be deemed to include, for purposes of this Section 6, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending or preparing to defend any such action or
claim. 
  

 - 16 - 

 Notwithstanding the provisions of this Section 6, no Holder shall be required to contribute any
amount in excess of the amount by which the total price at which the Transfer Restricted Securities purchased by it were resold exceeds the amount of any damages which such Holder has otherwise been required to pay by reason of any untrue or alleged
untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. The Holders’ obligations to contribute as provided in this Section 6(e) are several and not joint. 
  
 (f) The provisions of this Section 6 shall remain in full force and effect, regardless of any investigation made by or on behalf of
any Holder or the Company or any of the directors, officers, employees or controlling Persons referred to in this Section 6, and shall survive the sale by a Holder. 
  
 7. Rule 144A and Rule 144. The Company agrees with each Holder, for so long as any Transfer Restricted Securities
remain outstanding and during any period in which the Company (i) is not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request of any Holder, to such Holder or beneficial owner of Transfer Restricted
Securities in connection with any sale thereof and any prospective purchaser of such Transfer Restricted Securities designated by such Holder or beneficial owner, the information required by Rule 144A(d)(4) under the Securities Act in order to
permit resales of such Transfer Restricted Securities pursuant to Rule 144A, and (ii) is subject to Section 13 or 15(d) of the Exchange Act, to make all filings required thereby in a timely manner in order to permit resales of such
Transfer Restricted Securities pursuant to Rule 144. 
  
 8. No
Participation in Underwritten Registrations. No Holder may participate in any Underwritten Registration hereunder without the prior consent of the Company. 
  

9. Miscellaneous. 
  
 (a) Remedies. The Company acknowledges and agrees that any failure by the Company to comply with its obligations under
Section 2 hereof may result in material irreparable injury to the Investors or the other Holders for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely, and that, in the event
of any such failure, the Investors or any other Holder may obtain such relief as may be required to specifically enforce the Company’s obligations under Section 2 hereof. The Company further agrees to waive the defense in any action for
specific performance that a remedy at law would be adequate. 
  
 (b) Actions Affecting Transfer Restricted Securities. The Company shall not, directly or indirectly, take any action with respect to the Transfer Restricted Securities as a class that would adversely affect, in
any material respect, the ability of the Holders to include such Transfer Restricted Securities in a registration undertaken pursuant to this Agreement. 
  
 (c) No Inconsistent Agreements. The Company has not, as of the date hereof, entered into, nor shall it, on or after the date
hereof, enter into, any agreement with 

  

 - 17 - 

 
respect to its Common Stock or the Securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the
provisions hereof. In addition, the Company shall not grant to any of its securityholders (other than the Holders in such capacity) the right to include any of its securities in the Shelf Registration Statement provided for in this Agreement other
than the Transfer Restricted Securities. 
  
 (d)
Amendments and Waivers. This Agreement may not be amended, modified or supplemented, and waivers or consents to or departures from the provisions hereof may not be given, unless the Company has obtained the written consent of a Majority of
Holders. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter which relates exclusively to the rights of Holders whose securities are being sold pursuant to a Shelf Registration Statement
and does not directly or indirectly adversely affect the rights of other Holders in any material respect may be given by the Selling Holders holding more than 50% of the Transfer Restricted Securities outstanding that are held by the Selling
Holders. 
  
 (e) Notices. All notices and
other communications provided for or permitted hereunder shall be made in writing by hand delivery, first class mail (registered or certified, return receipt requested), telex, facsimile transmission or air courier guaranteeing overnight delivery:

  
 (i) if to a Holder, at the address set forth
on the records of the Company or the transfer agent of the Common Stock, as the case maybe; and 
  
 (ii) if to the Company, initially at its address set forth in the Purchase Agreement, 
  
 With a copy to: 
  
 BearingPoint, Inc. 
 1676 International Drive 
 McLean, VA 22102 
 Facsimile: (703) 747-3917 
 Attention: Chief Financial Officer 
  
 All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; five
(5) Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if transmitted by facsimile; and on the next Business Day, if timely delivered to an air courier
guaranteeing overnight delivery. 
  
 Any party hereto may change
the address for receipt of communications by giving written notice to the others. 
  
 (f) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of
the parties, including, without limitation, and without the need for an express assignment, subsequent Holders. The 

  

 - 18 - 

 
Company hereby agrees to extend the benefit of this Agreement to any Holder and any such Holder may specifically enforce the provisions of this Agreement as
if an original party hereto. 
  
 (g)
Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts (including by telecopier), each of which when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement. 
  
 (h) Securities Held by the Company or Its Affiliates. Whenever the consent or approval of Holders of a specified percentage of Transfer Restricted Securities is required hereunder, Transfer Restricted Securities held by the Company
or its Affiliates (other than subsequent Holders if such subsequent Holders are deemed to be Affiliates solely by reason of their holding of such Securities) shall not be counted in determining whether such consent or approval was given by the
Holders of such required percentage. 
  
 (i)
Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof 
  
 (j) Governing Law. This Agreement shall be governed by, and construed in accordance with, the law of the State of New York, without
giving effect to any conflict of law provisions thereof other than New York General Obligations Laws Sections 5-1401 and 5-1402. 
  
 (k) Severability. If any one or more of the provisions contained herein, or the application thereof in any circumstance, is held
invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or impaired thereby, it being intended that all of the
rights and privileges of the parties shall be enforceable to the fullest extent permitted by law. 
  
 (1) Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a
complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted by the Company with respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter.

  
 [remainder of page intentionally left blank; signature
page follows] 
  

 - 19 - 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	BEARINGPOINT, INC.
		
	By:	 	 /s/ Harry L. You

	Name:	 	Harry L. You
	Title:	 	Chief Executive Officer
	
	 FRIEDMAN FLEISCHER & LOWE
 CAPITAL PARTNERS II, L.P.

		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	  

	Name:	 	 
	Title:	 	 
	
	FFL PARALLEL FUND II, L.P.
		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	  

	Name:	 	 
	Title:	 	 
	
	FFL EXECUTIVE PARTNERS II, L.P.
		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	  

	Name:	 	 
	Title:	 	 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	BEARINGPOINT, INC.
		
	By:	 	  

	Name:	 	 
	Title:	 	 
	
	 FRIEDMAN FLEISCHER & LOWE
 CAPITAL PARTNERS II, L.P.

		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	 /s/ Spencer Fleischer

	Name:	 	Spencer Fleischer
	Title:	 	Vice Chairman
	
	FFL PARALLEL FUND II, L.P.
		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	 /s/ Spencer Fleischer

	Name:	 	Spencer Fleischer
	Title:	 	Vice Chairman
	
	FFL EXECUTIVE PARTNERS II, L.P.
		
	By:	 	 Friedman Fleischer & Lowe GP II, L.P., its general partner

	By:	 	 Friedman Fleischer & Lowe GP II, LLC, its general partner

		
	By:	 	 /s/ Spencer Fleischer

	Name:	 	Spencer Fleischer
	Title:	 	Vice Chairman

 Annex A 
  
 BEARINGPOINT, INC. 
 FORM OF SELLING
SECURITYHOLDER NOTICE AND QUESTIONNAIRE 
  
 The undersigned
beneficial holder of shares of common stock, par value $.01 per share, of BearingPoint, Inc. (“BearingPoint” or “Registrant”) understands that the Registrant has filed or intends to file with the Securities and
Exchange Commission (the “Commission”) a registration statement (the “Shelf Registration Statement”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”),
for the registration and resale of the Transfer Restricted Securities in accordance with the terms of the Registration Rights Agreement, dated as of July 15, 2005 (the “Registration Rights Agreement”), between
BearingPoint and the entities named as “Investors” therein. A copy of the Registration Rights Agreement is available from BearingPoint upon request at the address set forth below. Each capitalized term not otherwise defined herein shall
have the meaning ascribed thereto in the Registration Rights Agreement. 
  
 Each beneficial owner of Transfer Restricted Securities is entitled to the benefits of the Registration Rights Agreement. Holders of Transfer Restricted Securities will be required to deliver certain information to be used in connection
with the Shelf Registration Statement. In order to sell or otherwise dispose of any Transfer Restricted Securities pursuant to the Shelf Registration Statement, a beneficial owner of Transfer Restricted Securities generally will be required to be
named as a selling securityholder in the related prospectus, deliver a prospectus to purchasers of Transfer Restricted Securities and be bound by those provisions of the Registration Rights Agreement applicable to such beneficial owner (including
certain indemnification provisions, as described below). Beneficial owners are encouraged to complete and deliver this Notice and Questionnaire prior to the effectiveness of the Shelf Registration Statement so that such beneficial owners may be
named as selling securityholders in the related prospectus at the time of effectiveness. Any beneficial owner of Transfer Restricted Securities wishing to include its Transfer Restricted Securities must deliver to BearingPoint at the address set
forth herein a properly completed and signed Notice and Questionnaire. BearingPoint has agreed to pay liquidated damages pursuant to the Registration Rights Agreement under certain circumstances as set forth therein. 
  
 Certain legal consequences arise from being named as a selling securityholder
in the Shelf Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Transfer Restricted Securities are advised to consult their own securities law counsel regarding the consequences of being named or not
being named as a selling securityholder in the Shelf Registration Statement and the related prospectus. 

 NOTICE 
  
 The undersigned beneficial owner (the “Selling Securityholder”) of Transfer Restricted Securities hereby gives notice to
BearingPoint of its intention to sell or otherwise dispose of Transfer Restricted Securities beneficially owned by it and listed below in Item 3 (unless otherwise specified under Item 3) pursuant to the Shelf Registration Statement. The
undersigned, by signing and returning this Notice and Questionnaire, understands that it will be bound by the terms and conditions of this Notice and Questionnaire and the Registration Rights Agreement. 
  
 The undersigned hereby provides the following information to BearingPoint and
represents and warrants that such information is accurate and complete: 

 QUESTIONNAIRE 
  

							
	1. 	  	 (a)    
	  	Full legal name of Selling Securityholder:
			
	 	  	(b)	  	Full legal name of the broker-dealer or other third party through which Transfer Restricted Securities listed in Item 3 below are held:
			
	 	  	 	  	  

			
	 	  	(c)	  	Full legal name of DTC Participant (if applicable and if not the same as (b) above) through which Transfer Restricted Securities listed in Item 3 below are held:
			
	 	  	 	  	  

		
	2. 	  	Address for notices to Selling Securityholder:
			
	 	  	 	  	  

			
	 	  	 	  	  

			
	 	  	 	  	  

				
	 	  	 	  	Telephone:	  	  

				
	 	  	 	  	Fax:	  	  

				
	 	  	 	  	Contact Person:	  	  

		
	3. 	  	Beneficial ownership of Transfer Restricted Securities:
			
	 	  	(a)	  	Type and number of shares of Transfer Restricted Securities beneficially owned:
			
	 	  	 	  	  

			
	 	  	(b)	  	CUSIP No(s). of such Transfer Restricted Securities beneficially owned:
			
	 	  	 	  	  

		
	4. 	  	Beneficial ownership of other securities of BearingPoint owned by the Selling Securityholder:
		
	 	  	Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of BearingPoint other than the Transfer Restricted Securities
listed above in Item 3.

  

 A-3 

					
			
	 	 	(a)	  	Type and amount of other securities beneficially owned by the Selling Securityholder:
			
	 	 	 	  	  

			
	 	 	 	  	  

			
	 	 	(b)	  	CUSIP No(s). of such other securities beneficially owned:
			
	 	 	 	  	  

			
	 	 	 	  	  

		
	5. 	 	Relationship with BearingPoint:
		
	 	 	Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (5% or more) has held any position or office or has
had any other material relationship with BearingPoint (or its predecessors or affiliates) during the past three years. State any exceptions here:
		
	 	 	  

		
	 	 	  

		
	6. 	 	Nature of the Selling Securityholder:
			
	 	 	(a)	  	Is the Selling Securityholder a reporting company under the Exchange Act, a majority owned subsidiary of a reporting company under the Exchange Act, or a registered investment company under the
Investment Company Act, and if so, please state which one.
			
	 	 	 	  	  

			
	 	 	 	  	If the entity is a majority owned subsidiary of a reporting company, identify the majority stockholder that is a reporting company.
			
	 	 	 	  	  

			
	 	 	 	  	If the entity is not any of the above, identify the natural person or persons having voting and investment control over securities of BearingPoint that the entity owns.
			
	 	 	 	  	  

			
	 	 	(b)	  	Is the Selling Securityholder a registered broker-dealer?
			
	 	 	 	  	 ̈  Yes*    No   ̈

  

 A-4 

					
	 	 	 	 	State whether the Selling Securityholder received the Transfer Restricted Securities as compensation for underwriting activities and, if so, provide a brief description of the transaction(s)
involved.
			
	 	 	 	 	  

			
	 	 	 	 	  

			
	 	 	 	 	  

			
	 	 	 	 	  

			
	 	 	 	 	State whether the Selling Securityholder is an affiliate of a broker-dealer and if so, list the name(s) of the broker-dealer affiliate(s).
			
	 	 	 	 	 ̈  Yes*    No   ̈
			
	 	 	 	 	  

 *       If the answer is “Yes” to either question above, you must answer both the following questions:

			
	 	 	 	 	Were the Transfer Restricted Securities purchased in the ordinary course of business?
			
	 	 	 	 	 ̈  Yes*    No   ̈
			
	 	 	 	 	At the time of the purchase of the Transfer Restricted Securities, did the Selling Securityholder have any agreements or understandings, directly or indirectly, with any person to distribute the
Transfer Restricted Securities.
			
	 	 	 	 	 ̈  Yes*    No   ̈
			
	 	 	 	 	 **     If the answer is “Yes,” please describe such agreements or
understandings:

		
	 7.
	 	Plan of Distribution:
		
	 	 	Except as set forth below, the undersigned (including its donees or pledgees) intends to distribute the Transfer Restricted Securities listed above in Item 3 pursuant to the
Shelf Registration Statement only as follows (if at all): Such Transfer Restricted Securities may be sold from time to time directly by the undersigned or, alternatively, through underwriters, broker-dealers or agents. If the Transfer Restricted
Securities are sold through underwriters or broker-dealers, the Selling Securityholder will be responsible for underwriting discounts or commissions or agent’s commissions. Such Transfer Restricted Securities may be sold in one or more
transactions at fixed prices, at prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices. Such sales may be effected in transactions (which may involve block transactions) (i) on
any national securities exchange or quotation service on which the Transfer Restricted Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market or (iii) in transactions otherwise than on such exchanges or
services or in the over-the-counter market. The Selling Securityholder may pledge or grant a

  

 A-5 

									
	 	  	 	  	security interest in some or all of the Transfer Restricted Securities owned by it and, if it defaults in the performance of its secured obligations, the pledgees or secured parties
may offer and sell the Transfer Restricted Securities from time to time pursuant to the prospectus. The Selling Securityholder also may transfer and donate Transfer Restricted Securities in other circumstances in which case the transferees, donees,
pledgees or other successors in interest will be the selling securityholder for purposes of the prospectus.
				
	 	  	 	  	State any exceptions here:	  	  

			
	 	  	 	  	  

			
	 	  	 	  	Note: In no event will such method(s) of distribution take the form of an underwritten offering of the Transfer Restricted Securities without the prior agreement of
BearingPoint.

  
 The undersigned
acknowledges that it understands its obligation to comply with the provisions of the Exchange Act and the rules thereunder relating to stock manipulation, particularly Regulation M thereunder (or any successor rules or regulations) and the
provisions of the Securities Act relating to prospectus delivery, in connection with any offering of Transfer Restricted Securities pursuant to the Shelf Registration Statement. The undersigned agrees that neither it nor any person acting on its
behalf will engage in any transaction in violation of such provisions. 
  
 The Selling Securityholder hereby acknowledges its obligations under the Registration Rights Agreement to indemnify and hold harmless certain persons as set forth therein. 
  
 Pursuant to the Registration Rights Agreement, BearingPoint has agreed under certain circumstances to indemnify the Selling
Securityholder against certain liabilities. 
  
 In accordance with
the undersigned’s obligation under the Registration Rights Agreement to provide such information as may be required by law for inclusion in the Shelf Registration Statement, the undersigned agrees to promptly notify BearingPoint of any
inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Shelf Registration Statement remains effective. All notices hereunder and pursuant to the Registration Rights Agreement
shall be made in writing at the address set forth below. 
  
 By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 7 above and the inclusion of such information in the Shelf Registration Statement and the related prospectus. The
undersigned understands that such information will be relied upon by BearingPoint in connection with the preparation of amendment or the Shelf Registration Statement and the related prospectus. 
  
 By signing below, the undersigned agrees that if BearingPoint notifies the
undersigned that the Shelf Registration Statement is not available, the undersigned will suspend use of the prospectus until receipt of notice from BearingPoint that the prospectus is again available. 
  
 This Agreement shall be governed in all respects by the laws of the State of
New York. 
  

 A-6 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and
Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  
 Date: 
  

			
	Beneficial Owner
		
	By:	 	  

	Name:	 	 
	Title:	 	 

  
 PLEASE RETURN
THE COMPLETED AND EXECUTED NOTICE AND 
 QUESTIONNAIRE TO BEARINGPOINT, INC. AT: 
  
 BearingPoint, Inc. 
 1676 International Drive 
 McLean, Virginia 22102 
 Attn: Deputy General Counsel—Corporate and Securities 
  

 A-7Exhibit 10.81

 Exhibit 10.81 
  
 BEARINGPOINT, INC. 
 RESTRICTED STOCK UNIT AGREEMENT 
  
 BearingPoint,
Inc. (collectively with its subsidiaries and affiliates, the “Company”) has granted to the individual (the “Award Recipient”) named in the Award Notice of Restricted Stock Unit Grant (the
“RSU Award Notice”) to which this Restricted Stock Unit Agreement (the “Agreement”) is attached, an award consisting of restricted stock units, subject to the terms and conditions set forth in the RSU
Award Notice and this Agreement. The award has been granted pursuant to the BearingPoint, Inc. 2000 Long-Term Incentive Plan (the “Plan”). By signing the RSU Award Notice, the Award Recipient: (a) acknowledges receipt of
and represents that the Award Recipient has read and is familiar with the RSU Award Notice, this Agreement and the Plan, (b) accepts the award subject to all of the terms and conditions of the RSU Award Notice, this Agreement and the Plan and
(c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Compensation Committee (the “Committee”) of the Board of Directors of the Company regarding any questions arising under the RSU Award
Notice, this Agreement or the Plan. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the RSU Award Notice or the Plan. 
  
 1. Grant of Restricted Stock Units. 
  
 a. On the Grant Date, the Award Recipient shall acquire, subject to the provisions of this Agreement,
restricted stock units (the “Restricted Stock Units”) having the value set forth in the RSU Award Notice, subject to (i) the availability of Authorized Shares under Section 1.5(a) of the Plan and
(ii) adjustment by the Committee as provided in Section 7.7 of the Plan. Each Restricted Stock Unit consists of a bookkeeping entry representing the right to receive on a date determined in accordance with the RSU Award Notice and this
Agreement either (i) one share of Common Stock, or (ii) cash equal to the Fair Market Value of one share of Common Stock. 
  
 b. The Award Recipient is not required to make any monetary payment (other than applicable tax withholding, if any, and payment of the par
value of the Common Stock, if required by law) as a condition to receiving cash or shares of Common Stock issued upon settlement of the Restricted Stock Units, the consideration for which shall be future services to be rendered to the Company or for
its benefit. 
  
 2. Vesting of Restricted Stock Units.
Except as provided in Sections 4 and 7 of this Agreement, the Restricted Stock Units shall become vested and nonforfeitable in accordance with the Vesting Schedule set forth in the RSU Award Notice, provided, however, to the extent not already
vested, the Restricted Stock Units shall become 100% vested and nonforfeitable on the death or Disability of the Award Recipient while employed by the Company. 
  

3. Termination of Employment. 
  
 a. If the Award Recipient’s employment terminates for any reason or no reason, with or without “Cause,” other than on
account of death or Disability, the Award 

  

 1 

 
Recipient shall forfeit and the Company shall automatically reacquire all Restricted Stock Units which are not, as of the time of such termination, vested,
and the Award Recipient shall not be entitled to any payment or other consideration therefor, provided, however, that on the termination of the Award Recipient’s employment by the Company without “Cause” or by the Award
Recipient for “Good Reason,” the portion of the Restricted Stock Units that is scheduled to vest on the next Vesting Date specified in the RSU Award Notice shall vest on the date of the Award Recipient’s termination. 
  
 b. “Cause” shall mean the
occurrence, the failure to prevent the occurrence, or failure to cure after the occurrence (when a cure is permitted), as the case may be, of any of the following circumstances after the Award Recipient’s receipt of written notification from
the General Counsel which includes a detailed description of the claimed circumstance: (i) the Award Recipient’s embezzlement, misappropriation of corporate funds, or the Award Recipient’s material acts of dishonesty; (ii) the
Award Recipient’s commission or conviction of any felony or of any misdemeanor involving moral turpitude, or entry of a plea of guilty or nolo contendre to any felony or misdemeanor involving moral turpitude; (iii) the Award
Recipient’s engagement, without a reasonable belief that his or her action was in the best interests of the Company, in any activity that could harm the business or reputation of the Company in a material manner; (iv) the Award
Recipient’s willful failure to adhere to the Company’s material corporate codes, policies or procedures that have been communicated to him or her; or (v) the Award Recipient’s violation of any statutory or common law duty or
obligation to the Company, including, without limitation, the duty of loyalty, provided, however, that in the case of clauses (iii), (iv) and (v), the Company shall provide the Award Recipient with the opportunity to cure any
Cause event during the 15-day period after his or her receipt of written notice describing the Cause event, and provided, further, that a Cause event shall be considered to be cured only if all adverse consequences of the Cause event
have been fully remedied. 
  
 c. “Good
Reason” shall mean the occurrence or failure to cause the occurrence, as the case may be, without the Award Recipient’s express written consent, of any of the following circumstances for more than 15 days after receipt by the
General Counsel of the Company of the Award Recipient’s written notification and description of the claimed circumstance: (i) any adverse change in the Award Recipient’s then positions, titles or reporting obligations, or a material
diminution of the Award Recipient’s duties, responsibilities or authority or the assignment to the Award Recipient of duties or responsibilities that are materially adversely inconsistent with the Award Recipient’s position, (ii) a
relocation of the Award Recipient’s office to a location more than 75 miles from the Award Recipient’s office on the initial Grant Date, (iii) any material breach by the Company of any provision of the Managing Director Agreement with
the Award Recipient or (iv) the failure of any successor to the Company (whether direct or indirect and whether by merger, acquisition, consolidation or otherwise) to assume in a writing delivered to the Award Recipient upon the successor
becoming such, the obligations of the Company under this Agreement, provided, however, that this clause shall not apply if the transaction results in the successor becoming legally required to fulfill the obligations of the Company
under this Agreement, whether by operation of law or otherwise. 
  

 2 

 4. Termination of Restricted Stock Units and Forfeiture of Restricted Stock Units Gain.

  
 a. If the Award Recipient: 
  
 i. breaches any covenant concerning confidentiality or
intellectual property or concerning noncompetition or nonsolicitation of clients, prospective clients or personnel of the Company and its Affiliates to which the Award Recipient is or may become a party in the future; 
  
 ii. fails (A) to complete on a timely basis all current
and future training relating to the Company’s policies and procedures, including financial reporting and timekeeping training, (B) to consistently follow all Company policies and procedures and to confirm that the employees the Award
Recipient supervises are following such Company policies and procedures, (C) to meet such cash collection goals, if any, as are established for the Award Recipient by the Company from time to time or (D) to participate in the
Company’s variable compensation program; or 
  
 iii. is terminated for “Cause;” 
  
 then, in
addition to and without in any way limiting any remedies under any of the covenants described above in this Section 4(a) or otherwise: 
  
 (A) any unvested Restricted Stock Units and any vested Restricted Stock Units that have not settled as provided in Section 5(a) shall be forfeited
automatically on the date the Award Recipient commits such breach as is specified in clause (i), fails to act as specified in clause (ii) or is terminated for “Cause;” and 
  
 (B) in the event of a breach described in Section 4(a)(i), the Award Recipient shall pay the Company, within five
business days of receipt by the Award Recipient of a written demand therefor, an amount in cash equal to the aggregate of (i) cash received in settlement of Restricted Stock Units and (ii) the amount determined by multiplying the number of
shares of Common Stock issued in settlement of Restricted Stock Units prior to the date the Award Recipient breaches such covenant (without reduction for any shares of Common Stock delivered by the Award Recipient or withheld by the Company pursuant
to Section 6(c)) by the Fair Market Value of a share of Common Stock on the date the shares of Common Stock were issued to the Award Recipient; and 
  
 (C) in the event of a breach described in Section 4(a)(ii) or if the Award Recipient is terminated for Cause other than for a breach referenced in
Section 4(a)(i), the Award Recipient shall pay the Company, within five business days of receipt by the Award Recipient of a written demand therefor, an amount in cash equal to 50% of the aggregate of (i) cash received in settlement of
Restricted Stock Units and (ii) the amount determined by multiplying the number of shares of Common Stock issued in settlement of Restricted Stock Units prior to the date of the breach described in Section 4(a)(ii) or the date the Award
Recipient is terminated for Cause other than for a breach referenced in Section 4(a)(i) (without reduction 

  

 3 

 
for any shares of Common Stock delivered by the Award Recipient or withheld by the Company pursuant to Section 6(c)) by the Fair Market Value of a share
of Common Stock on the date the shares of Common Stock were issued to the Award Recipient; and 
  
 (D) the Award Recipient shall pay any damages in excess of the amounts paid to the Company under clauses (B) or (C) above. 
  
 b. The Award Recipient agrees that by executing the RSU
Award Notice, the Award Recipient authorizes the Company and its Affiliates to deduct any amount or amounts owed by the Award Recipient pursuant to Section 4(a) from any amounts payable by the Company or any Affiliate to the Award Recipient,
including, without limitation, any amount payable to the Award Recipient as salary, wages, vacation pay or bonus. This right of setoff shall not be an exclusive remedy, and the Company’s or an Affiliate’s election not to exercise this
right of setoff with respect to any amount payable to the Award Recipient shall not constitute a waiver of this right of setoff with respect to any other amount payable to the Award Recipient or any other remedy. 
  
 5. Settlement of the Restricted Stock Units. 
  
 a. Issuance of Shares of Common Stock or Cash.
Subject to the provisions of Sections 1(a), 5(b), 5(c) and 5(d), the Company shall issue to the Award Recipient, on the Settlement Date with respect to each Restricted Stock Unit to be settled on such date, (i) the number of shares of Common
Stock that is equal to the number of vested Restricted Stock Units, after any adjustments under Section 7.7 of the Plan, calculated in accordance with the Settlement Schedule contained in the RSU Award Notice, (ii) cash or (iii) a
combination of cash and shares of Common Stock, provided that each Restricted Stock Unit shall be settled in the form specified in clause (i), unless the Committee, in its sole discretion, specifies prior to the Settlement Date that the
issuance shall be in the form specified in clause (ii) or clause (iii), and provided further that any Restricted Stock Units that vest as a result of the death or Disability of the Award Recipient shall be settled in full on the next
Settlement Date specified in the Settlement Schedule that occurs after the death or Disability of the Award Recipient. If the Committee elects to pay the Award Recipient in cash, the payment shall equal the Fair Market Value of the number of shares
of Common Stock on the Settlement Date that is equal to the number of vested Restricted Stock Units, after any adjustments under Section 7.7 of the Plan, calculated in accordance with the Settlement Schedule contained in the RSU Award Notice.
Shares of Common Stock issued in settlement of Restricted Stock Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Sections 5(b), 5(c) or 5(d). 
  
 b. If the Award Recipient terminates his or her employment,
other than for Good Reason or on account of death or Disability, then (i) the Company shall not issue to the Award Recipient any additional shares of Common Stock underlying outstanding vested Restricted Stock Units pursuant to
Section 5(a) of this Agreement until January 1, 2015, at which time any outstanding vested Restricted Stock Units shall be settled as provided in Section 5(a), and (ii) the Award Recipient shall not sell, assign, alienate,
pledge, attach or otherwise transfer 

  

 4 

 
or encumber any shares of Common Stock previously issued to the Award Recipient pursuant to Section 5(a) until January 1, 2015. 
  
 c. Restrictions on Grant of the Restricted Stock Units
and Issuance of Shares. The grant of the Restricted Stock Units and issuance of shares of Common Stock upon settlement of the Restricted Stock Units shall be subject to and in compliance with all applicable requirements of federal, state or
foreign law with respect to such securities. No shares of Common Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the
requirements of any stock exchange or market system upon which the Common Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel
to be necessary to the lawful issuance of any shares subject to the Restricted Stock Units shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained.
As a condition to the settlement of the Restricted Stock Units, the Company may require the Award Recipient to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make
any representation or warranty with respect thereto as may be requested by the Company. 
  
 d. Restrictions on Sale of Shares. Until January 1, 2015, the Award Recipient shall not transfer any shares of Common Stock
received upon the settlement of Restricted Stock Units pursuant to Section 5(a) except (i) in sales, redemptions or other transactions, underwritten public offerings or share repurchases, in each case as approved in writing by the Company
either specifically or by general policy, or (ii) to estate and/or tax planning vehicles, family members and charitable organizations that become bound hereby by express agreement, in each case as approved in writing by the Company (which
approval may be subject to such other conditions, including the requirement that any transferee become bound by any other agreement, as the Company may, in its sole discretion, require). The Company shall use its reasonable efforts to facilitate the
sales, redemptions or other transactions, underwritten public offerings or share repurchases referred to in clause (i) of the preceding sentence, at the Company’s expense, promptly after each settlement of the Restricted Stock Units. The
Award Recipient agrees that, in the Company’s sole discretion, and until January 1, 2015, all of his or her shares of Common Stock shall either (i) bear legends that reflect the restrictions imposed by this Section 5 or
(ii) be held in custody by a custodian designated by the Company. 
  
 e. Registration of Shares. Shares issued in settlement of the Restricted Stock Units shall be registered in the name of the Award Recipient, or, if applicable, in the names of the heirs of the Award Recipient.
Such shares may be issued either in certificated or book entry form. In either event, the certificate or book entry account shall bear such restrictive legends or restrictions as the Company, in its sole discretion, shall require. 
  
 f. Fractional Shares. The Company shall not be
required to issue fractional shares upon settlement of the Restricted Stock Units. 
  

 5 

 g. Dividend Equivalents. As of each dividend payment date for each cash dividend
on the Common Stock, the Award Recipient shall receive additional restricted stock units, which shall be subject to the same terms and conditions as the Restricted Stock Units granted pursuant to the RSU Award Notice and this Agreement. The number
of additional restricted stock units to be granted shall equal: (i) the product of (x) the per-share cash dividend payable with respect to each share of Common Stock on that date, multiplied by (y) the total number of Restricted Stock
Units which have not been settled or forfeited as of the record date for such dividend, divided by (ii) the Fair Market Value of one share of Common Stock on the payment date of such dividend. 
  
 6. Withholding Taxes. 
  
 a. In General. Unless Section 6(b) or
Section 6(c) applies, the Award Recipient shall pay to the Company, or make provision satisfactory to the Company for payment of, any federal, state, local or foreign taxes required by law to be withheld with respect to the issuance of shares
of Common Stock in settlement of any Restricted Stock Units, no later than the date required by law (the “Tax Date”). The Company shall have no obligation to deliver shares of Common Stock until the tax withholding obligations of the
Company have been satisfied by the Award Recipient. 
  
 b. Payment in Cash. The Company shall withhold from any payment under Section 5(a) the amount of any federal, state, local or foreign taxes required by law to be withheld with respect to the settlement of the Restricted Stock
Units in cash. 
  
 c. Payment in Shares.
The Award Recipient may satisfy all or any portion of the Company’s tax withholding obligations by requesting the Company, in its sole discretion, to withhold a number of whole shares of Common Stock otherwise deliverable to the Award Recipient
in settlement of the Restricted Stock Units having a Fair Market Value, as of the Tax Date, not in excess of the amount of such tax withholding obligations determined by the applicable minimum statutory withholding rates. Any adverse consequences to
the Award Recipient resulting from the procedure permitted under this Section 6(c), including, without limitation, tax consequences, shall be the sole responsibility of the Award Recipient. 
  
 7. Change in Control. In the event of a Change in Control of the
Company, the Restricted Stock Units shall become 100% vested and nonforfeitable effective as of the date of the Change in Control, provided that the Award Recipient’s employment has not terminated prior to such date. The Restricted Stock Units
shall be settled in accordance with Section 5(a) on the date of the Change in Control, and all restrictions on the sale of Company Common Stock under Section 5 shall terminate on the date of the Change of Control. 
  
 8. Rights as a Stockholder. The Award Recipient shall have no rights
as a stockholder with respect to any shares which may be issued in settlement of the Restricted Stock Units until either (i) a certificate is issued for such shares or (ii) an appropriate entry is made in the account of the Award Recipient
evidencing that such shares are owned by the Award Recipient. No adjustment shall be made for dividends, distributions or other rights for which the 

  

 6 

 
record date is prior to the date such certificate is issued or an appropriate entry is made in the account of the Award Recipient evidencing that such shares
are owned by the Award Recipient, except as provided in Section 7.7 of the Plan and Section 5(e) of this Agreement. 
  
 9. No Employment Rights. The Award Recipient acknowledges that the Award Recipient’s employment is “at will” and is for no specified
term. Nothing in this Agreement shall confer upon the Award Recipient any right to continue in the employment of the Company or interfere in any way with any right of the Company to terminate the Award Recipient’s employment at any time.

  
 10. Legends. The Company may at any time place legends
referencing any restrictions, including, without limitation, applicable federal, state or foreign securities law restrictions, on all certificates representing shares of Common Stock issued pursuant to this Agreement. The Award Recipient shall, at
the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Agreement in the possession of the Award Recipient in order to carry out the provisions of this Section. 

 
 11. Nontransferability of Restricted Stock Units. Neither this
Agreement nor any of the Restricted Stock Units subject to this Agreement shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Award Recipient or the
Award Recipient’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Agreement shall be exercisable during the Award Recipient’s lifetime only by the Award Recipient or the Award
Recipient’s guardian or legal representative. 
  
 12.
Amendment. The Committee may amend this Agreement at any time, provided, however, that no such amendment may adversely affect the Award Recipient’s rights under this Agreement without the consent of the Award Recipient,
except to the extent such amendment is reasonably determined by the Committee, in its sole discretion, to be necessary to comply with applicable law or to prevent a detrimental accounting impact. No amendment or addition to this Agreement shall be
effective unless in writing. 
  
 13. Waivers; Exceptions.
Any provision or requirement of this Agreement may be waived and any exception to the terms of this Agreement may be granted, in each case, generally or specifically, in whole or in part, and subject to any conditions, by the Committee or the Chief
Executive Officer of the Company. 
  
 14. Administration of
this Agreement. All questions of interpretation concerning the RSU Award Notice and this Agreement shall be determined by the Committee. All determinations by the Committee shall be final and binding upon all persons having an interest in the
award. 
  
 15. Binding Effect. This Agreement shall inure
to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding 

  

 7 

 
upon the Award Recipient and the Award Recipient’s heirs, executors, administrators, guardians, legal representatives, successors and assigns.

  
 16. Integrated Agreement. The RSU Award Notice, this
Agreement and the Plan constitute the entire understanding and agreement of the Award Recipient and the Company with respect to the subject matter contained herein or therein and supersedes any prior agreements, understandings, restrictions,
representations or warranties among the Award Recipient and the Company with respect to such subject matter other than those as set forth or provided for herein or therein. To the extent contemplated herein or therein, the provisions of the RSU
Award Notice and the Agreement shall survive any settlement of the award and shall remain in full force and effect. 
  
 17. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia, other than the
conflict of laws principles thereof. 
  
 18. Construction.
Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural
shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise. 
  
 ***** 
  

 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]